Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
Clinical trial NCT02177136 · COMPLETED
Trial details
- NCT number
- NCT02177136
- Sponsor
- Intercept Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-09
- Primary completion
- 2017-03-07
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.